447 related articles for article (PubMed ID: 25727149)
1. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
2. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
3. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
Ferreira JA; Magalhães A; Gomes J; Peixoto A; Gaiteiro C; Fernandes E; Santos LL; Reis CA
Cancer Lett; 2017 Feb; 387():32-45. PubMed ID: 26828132
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.
Chik JH; Zhou J; Moh ES; Christopherson R; Clarke SJ; Molloy MP; Packer NH
J Proteomics; 2014 Aug; 108():146-62. PubMed ID: 24840470
[TBL] [Abstract][Full Text] [Related]
6. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
7. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
8. (Sialyl)Lewis antigen expression on glycosphingolipids, N- and O-glycans in colorectal cancer cell lines is linked to a colon-like differentiation program.
Wang D; Madunić K; Mayboroda OA; Lageveen-Kammeijer GSM; Wuhrer M
Mol Cell Proteomics; 2024 Apr; ():100776. PubMed ID: 38670309
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
10. Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays.
Rho JH; Mead JR; Wright WS; Brenner DE; Stave JW; Gildersleeve JC; Lampe PD
J Proteomics; 2014 Jan; 96():291-9. PubMed ID: 24185138
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype.
Madunić K; Zhang T; Mayboroda OA; Holst S; Stavenhagen K; Jin C; Karlsson NG; Lageveen-Kammeijer GSM; Wuhrer M
Cell Mol Life Sci; 2021 Jan; 78(1):337-350. PubMed ID: 32236654
[TBL] [Abstract][Full Text] [Related]
13. Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines.
Sethi MK; Thaysen-Andersen M; Smith JT; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Jan; 13(1):277-88. PubMed ID: 24295106
[TBL] [Abstract][Full Text] [Related]
14. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
[TBL] [Abstract][Full Text] [Related]
15. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation and cancer: moving glycomics to the forefront.
Drake RR
Adv Cancer Res; 2015; 126():1-10. PubMed ID: 25727144
[TBL] [Abstract][Full Text] [Related]
17. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
18. Precise structural analysis of O-linked oligosaccharides in human serum.
Yabu M; Korekane H; Miyamoto Y
Glycobiology; 2014 Jun; 24(6):542-53. PubMed ID: 24663386
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells.
Misonou Y; Shida K; Korekane H; Seki Y; Noura S; Ohue M; Miyamoto Y
J Proteome Res; 2009 Jun; 8(6):2990-3005. PubMed ID: 19292502
[TBL] [Abstract][Full Text] [Related]
20. Integrated mass spectrometric strategy for characterizing the glycans from glycosphingolipids and glycoproteins: direct identification of sialyl Le(x) in mice.
Parry S; Ledger V; Tissot B; Haslam SM; Scott J; Morris HR; Dell A
Glycobiology; 2007 Jun; 17(6):646-54. PubMed ID: 17341505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
